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              B-1 cells are a small subset of B cells that se-
crete most, if not all, natural antibodies in the 
apparent absence of antigenic challenge. Natu-
ral antibodies are often polyreactive and bind to 
foreign antigens as well as to self-components 
(  1  –  4  ). B-1 cell  –  derived natural antibodies are 
crucial for host survival from infections. De-
fects in their production cause increased deaths 
after infection with bacteria, such as   Salmonella 
typhimurium   and   Streptococcus pneumoniae   (  5  –  7  ), 
and viruses, such as vesicular stomatitis virus, 
lymphocytic choriomeningitis virus, vaccinia 
virus, and infl  uenza (  2, 8  ). 
  B-1 cells are composed of two sister popu-
lations, CD5  +   B-1a and CD5        B-1b (  9  ). In ad-
dition to their disparate expression of CD5, 
B-1a and B-1b cells appear also to diff  er de-
velopmentally and functionally (  10  ). Develop-
mental diff   erences between B-1a and B-1b 
cells were identifi  ed by exploiting a hallmark of 
B-1 cells, namely their ability to self-replenish 
(  11  ). B-1a and B-1b cell subsets are thought to 
replenish only themselves and not the other sis-
ter population. Although the mechanisms un-
derlying B-1 cells  ’   ability to self-replenish are 
not understood, earlier studies by Lalor et al. 
(  12  ) revealed a homeostatic regulatory mecha-
nism by which the presence of normal numbers 
of B-1 cells in the peritoneal cavity sup  presses 
further B-1 cell expansion and/or de novo 
development. 
  The diff  erence in CD5 expression between 
B-1a and B-1b cells might be a crucial factor de-
termining their in vivo responsiveness to patho-
gen invasion. CD5 acts as a negative regulator of 
B cell receptor (BCR)  –  mediated activation sig-
nals (  13  ) and renders B-1a cells nonresponsive to 
in vitro BCR cross-linking (  14  ). Consistent with 
the expression of the inhibitor CD5 on B-1a but 
not B-1b cells, only CD5        B-1b cells were 
shown to clonally expand in vivo after infection 
with   Borrelia hermsii  . After transfer into Rag1      /      
mice, B-1b cells rendered recipients protected 
from   B. hermsii   challenge (  15, 16  ). Although B-
1a cells also contributed to immune protection 
in that system, this was thought to be mediated 
via natural antibody production. Furthermore, 
B-1b cells formed strong anti  –  PPS-3 (pneumo-
coccal polysaccharide-3) immune responses after 
immunization with either PPS-3 or heat-killed 
  S. pneumoniae   and conferred immunity against   
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  B-1 cells are known to contribute most of the   “  natural antibodies  ”   that are secreted in the 
steady state, antibodies which are crucial for protection against many pathogens including 
infl  uenza virus. Whether the CD5  +   B-1a subset plays a role during an active immune re-
sponse is incompletely understood. In contrast to recent data suggesting a passive role for 
B-1a cells, data provided here show strong highly localized activation of B-1 cells in the 
draining lymph nodes of the respiratory tract after infl  uenza infection. B-1 cells are identi-
fi  ed as a major source for both steady state and infection-induced local virus-neutralizing 
IgM. The CD5  +   B-1a subset is the main B-1 cell subset generating this response. B-1a cell 
responses are generated by their increased local accumulation rather than by antigen-
specifi  c expansion. Our study reveals that during infection with infl  uenza, CD5-expressing 
B-1a cells respond to and contribute to protection, presumably without the need for B cell 
receptor  –  mediated antigen-specifi  c signals, which are known to induce the death of B-1a 
cells rather than activation. With that, our data reveal fundamental differences in the 
response regulation of B-1 and B-2 cells during an infection. 
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cells rather than activation. With that, our data also reveal 
fundamental diff  erences in the response regulation of B-1 and 
B-2 cells during an infection. 
    RESULTS   
  We previously showed that B-1 cells importantly contribute 
to protection from infl  uenza virus infection via secretion of 
IgM (  2, 26  ). Consistent with our fi  ndings, others recently 
showed a requirement for BLIMP-1 (B lymphocyte  –  induced 
maturation protein 1)  –  dependent diff  erentiation to antibody-
secreting cells for B-1 cell  –  mediated protection from infl  u-
enza infection (  27  ). The protective eff  ects of B-1 cells did 
not appear to require infection-induced enhanced B-1 cell  – 
derived IgM secretion, as serum IgM levels were unchanged 
after infection and passive transfer of serum from noninfected 
WT mice at least partially restored protection (  26  ). However, 
typical infl  uenza virus infection is highly restricted to the re-
spiratory tract and protection might be mediated by local im-
mune defense mechanisms. Because IgM can be transported 
onto the mucosal surface of the respiratory tract (  24, 25  ), we 
aimed to study the potential contributions of B-1 cells to the 
local immune responses against infl  uenza virus. 
  A challenge for studies on B-1 cells in the physiological 
context of an intact host is the lack of a specifi  c marker that 
distinguishes all B-1 cells from conventional (B-2) cells. To 
overcome this hurdle, we generated Ig allotype chimeras by 
neonatal allotype-specifi  c anti-IgM treatment and adoptive 
transfer of allotype-disparate congenic peritoneal cavity wash-
out cells (PerC) according to previously published protocols 
(  2, 12  ). After full reconstitution, these mice contain B-1 and 
B-2 cells of disparate allotypes (Igh-a and Igh-b, respectively 
for the studies in this paper) as described in detail elsewhere 
(  2  ). B-1 and B-2 cells and the antibodies they produce are 
distinguished using Ig allotype and isotype-specifi  c monoclo-
nal antibodies. As shown earlier, in these chimeras all donor-
derived Igh-a is of B-1 cell origin and 80  –  90% of the host 
Igh-b is B-2 cell derived (  2  ). For easier reading of the text we 
will refer to donor and host-derived Ig as B-1 and B-2 cell 
derived, respectively. 
  B-1 cells produce natural IgM in the respiratory tract 
  Using these mice we confi  rmed our previous fi  ndings that 
most of the serum natural IgM was Igh-a (87   ±   3.4%;   Fig. 1 A  ) 
and thus was produced by B-1 cells.   We also detected steady 
state  –  secreted natural IgM in the bronchoalveolar lavage 
(BAL). Somewhat surprisingly, B-1 cells provided   >  99% of 
natural infl   uenza-binding IgM in the airway space (88   ±   
14 U/mg for B-1 and 0.4   ±   0.01 U/mg for B-2;   Fig. 1 B  ). 
Given that small amounts of natural infl  uenza-binding IgM 
might be produced by host-derived B-1 cells (  2  ), it is likely 
that all respiratory tract IgM in the steady state is B-1 cell de-
rived. Consistent with this, B-1 cells generated   >  90% of the 
natural total and virus-specifi  c IgM-secreting antibody-form-
ing cells (AFCs) in lung tissue as measured by ELISPOT (  Fig. 
1 C  ). Overall, IgM secretion in the chimeras was comparable 
to that of BALB/c mice, indicating that allotype chimera 
S. pneumoniae   after their adoptive transfer into Rag1      /      recipi-
ent mice (  17  ). B-1a cells did not mount anti  –  PPS-3 responses 
after immunization with heat-killed   S. pneumoniae  . Instead, they 
secreted high amounts of natural antibodies against phosphocho-
line, which is another antigenic determinant on   S. pneumoniae   
(  17  ). B-1b cells were also shown to mount long-term antibody 
responses to TI-2 (thymus-independent type-2) antigen, NP-
Ficoll (4-hydroxy-3-nitrophenyl-acetyl conjugated to the 
polysaccharide Ficoll) (  18  ). 
  Collectively, these data were interpreted as evidence for a 
mainly passive role for CD5  +   B-1a cells as producers of natu-
ral antibodies and an active role for B-1b cells (  19  ). However, 
the results from those recent studies are in apparent contrast 
to earlier studies that had demonstrated an active participa-
tion of B-1a cells to   S. pneumoniae   (  20, 21  ). Those earlier 
studies demonstrated that immunization led B-1a cells to gen-
erate the robust and dominant T15 idiotype antibody response 
to phosphocholine (  20, 21  ), which provides immune protec-
tion against reinfection with   S. pneumoniae   (  22  ). Furthermore, 
although B-1a cells do not respond to BCR-mediated signals 
they strongly respond to various innate signals both in vivo and 
in vitro (  13, 23  ). 
  Natural antibodies produced by B-1 cells are mostly of the 
IgM isotype (  1  ). Thus, these antibodies can also be transported 
via the polymeric Ig receptor onto mucosal surfaces and con-
tribute to mucosal immune defenses (  24, 25  ). We previously 
showed that natural IgM secretion by B-1 cells is required for 
maximal protection against infl  uenza virus  –  induced deaths by 
demonstrating enhanced mortality of mice that lacked B-1 
cell  –  derived IgM but had normal levels of B-2 cell IgM 
(  2, 26  ). This enhanced mortality after infl  uenza virus infection 
was partially restored by transfer of natural IgM-containing 
serum from noninfected WT mice, whereas serum from se-
cretory IgM KO mice (sIgM      /     ) had no eff  ect. Lung viral 
titers were signifi   cantly higher in infl  uenza  virus  –  infected 
sIgM      /      mice compared with WT controls (  26  ). Because B-1 
cell  –  derived virus-binding serum IgM levels were unaltered 
after infection, we concluded in our earlier studies that B-1 
cells play a mainly passive role in immune protection to infl  u-
enza (  2  ), which is consistent with the fi  ndings of others (  8  ). 
  Given the apparent contradictory data on B-1 cells, in 
particular B-1a cells, regarding their contributions to the ac-
tive humoral response, we reexamined the responsiveness of 
B-1 cells to infection with infl  uenza virus in the physiological 
context of an intact immune system. Collectively our data 
show strong highly localized activation of B-1 cells in the 
draining LN of the respiratory tract after infl  uenza infection 
and identify B-1 cells as a major source for local virus-neu-
tralizing IgM. The CD5  +   B-1a subset was the main B-1 cell 
subset generating this response. The response was generated 
by increased local accumulation of B-1a cells, but not B-1b 
cells, rather than by antigen-specifi  c expansion. Our study 
thus reveals that during infection with infl  uenza, CD5-ex-
pressing B-1a cells respond to and contribute to protection, 
presumably without the need for BCR-mediated antigen-
specifi  c signals, which are known to induce death of B-1a JEM VOL. 205, December 22, 2008 
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BAL during the course of infection, whereas B-2 cell  –  derived 
IgM was only weakly induced (  Fig. 2 B  ). Local IgM responses 
in WT BALB/c mice showed similar kinetics to the allotype 
chimeras (  Fig. 2 B  ). These results show a remarkable dichotomy 
in the response of B-1 cells to infection with infl  uenza virus. 
have normal levels of local natural IgM (  Fig. 1  ). The slightly 
higher expression in the chimeras is likely because of the dif-
ferent ages used for comparison (8  –  10 wk and   >  4 mo for 
BALB/c mice and chimeras, respectively) and does not re-
fl  ect diff  erences caused by the generation of the chimeras. 
The data confi  rm and extend previous studies on the impor-
tance of B-1 cells as producers of much of the steady state 
IgM produced systemically in serum (  2, 26  ) as well locally in 
the respiratory tract as shown here. 
  Induction of local B-1 cell responses after infl  uenza 
virus infection 
  Although B-1 cells contribute most of the preinfection infl  u-
enza-binding serum IgM, the enhanced systemic production 
of serum IgM after infection with this virus is exclusively B-2 
cell derived (  2  ). We evaluated the contributions of B-1 and 
B-2 cells to local respiratory tract IgM production after infec-
tion by conducting allotypes-specifi  c ELISA with BAL and 
serum from two litters of allotype chimeras. One litter was 
studied at days 0, 5, and 7 after infection and the other at days 
7 and 10. Confi  rming our previous studies, neither systemic 
virus-specifi  c (  Fig. 2 A  ) nor total (not depicted) B-1 cell  – 
derived IgM titers were altered in the serum after infection, 
whereas B-2 cell  –  derived IgM was strongly induced (  Fig. 2 A  ).   
In stark contrast to the systemic response, local B-1 cell  –
  derived infl  uenza-binding IgM was strongly increased in the 
    Figure 1.         B-1 cells are major producers of natural IgM in serum 
and airways.   (A) Shown are relative amounts of B-1 and B-2 cell  –  derived 
total serum IgM in noninfected Ig allotype chimeras (  n   = 5) measured by 
ELISA. As shown previously (  2  ), B-1 cells (Igh-a) are the main source of 
serum IgM (black; 87   ±   3.4% of total IgM). (B) Shown are mean concen-
trations   ±   SD of total (left) and virus IgM (right) per milligrams of total 
protein, derived from B-1 (Igh-a; black) and B-2 (Igh-b; white) cells in the 
BLF of chimeras (  n   = 2). Data for BALB/c mice (  n   = 4; hatched bars) are 
shown for comparison. (C) Shown are the mean frequencies   ±   SD of total 
(left) and virus-specifi  c (right) IgM-secreting cells in the lung tissue of the 
same chimeras and control BALB/c mice. Data are from one of three ex-
periments done with chimeras that yielded comparable results.     
    Figure 2.         B-1 cells respond to infl  uenza infection locally but not 
systemically with increased IgM production.   Shown are serum (A) and 
BLF (B) IgM levels from individual Ig allotype chimeras and BALB/c mice, 
respectively, at indicated times after infl  uenza A/Mem/71 infection. Two 
groups of mice were analyzed (experiment (Expt.) 1 and experiment 2,   n   = 
2  –  4 mice per time point). B-1 (A and B, circles) and B-2 (A and B, squares) 
cell – derived  virus-specifi  c IgM levels (in units per milliliter) were deter-
mined in chimeras by allotypes-specifi  c IgM ELISA. IgM concentrations in 
BLF were normalized to total protein concentrations (in units per milli-
gram). BLF data for BALB/c mice (B, diamonds) are shown for comparison. 
Results represent one of two sets of experiments done that yielded com-
parable results. Statistical analysis was conducted using ONE-way ANOVA 
(Tukey  ’  s multiple comparison test: *, P   <   0.05; **, P   <   0.01; ***, P   <   0.001).     3056 LOCAL B-1A CELL RESPONSES DURING INFLUENZA INFECTION   | Choi and Baumgarth 
CD43 (  Fig. 4 D  ). The IgM  +  CD43  +   B cell population was the 
only signifi  cant source of IgM-secreting cells (  Fig. 4 D  ). They 
expressed the same phenotype as the B-1 cells identifi  ed in 
the allotype chimeras (see following paragraph), namely FS-
C  hi   CD19  hi   IgM  hi   IgD  lo   CD43  +   (  Fig. 4   and not depicted). 
Although systemic natural IgM levels are maintained at the 
steady state, B-1 cells respond strongly with increased IgM 
secretion in a tissue-restricted manner at the site of infection. 
  Antiviral activity of locally secreted IgM 
  To determine the functional signifi  cance of local B-1 cell IgM 
secretion, we studied the antiviral properties of IgM in the BAL 
fl  uid (BLF) using a chicken RBC hemagglutination inhibition 
(HI) assay. We could use BLF from BALB/c mice instead of 
having to generate chimeras because   >  99% of preinfection in-
fl  uenza-binding IgM is produced by B-1 cells (  Fig. 1 B  ). We 
compared HI activity in BLF taken at days 0 and 7 of infection, 
both before and after removal of IgM via affi   nity chromatogra-
phy. ELISA analysis confi  rmed the successful removal of virus 
IgM in these samples (  Fig. 3 A  ).   The removal of IgM reduced 
the antiviral HI activity by   >  75% when BLF was received from 
noninfected mice and to     50% when BLF was taken on day 7 
of infection (  Fig. 3 B  ). The smaller contributions of IgM in 
BLF from infected mice are explained by the increases in virus-
specifi  c antibodies of other isotypes (  Fig. 3 C  ). Thus, B-1 
cell  –  derived IgM has relevant functional antiviral activity. 
Furthermore, the data suggest that B-1 cells provide immune 
protection to infl  uenza virus by two distinct mechanisms: the 
generation of steady-state systemic and local natural antibodies 
and the rapid local induction of antiviral IgM by actively par-
ticipating in local humoral response to infl  uenza virus infection. 
This provides an explanation for why transfer of natural IgM 
only in part reconstituted protection from infl  uenza-induced 
death in mice that lacked IgM-secreting B-1 cells (  26  ). 
  Effector B-1 cells accumulate in the mediastinal 
LN (MedLN) after infl  uenza virus infection 
  To determine the site of B-1 cell  –  induced IgM secretion after 
infl  uenza virus infection, we performed ELISPOT analysis on 
regional MedLN as well as on spleen and lung tissue. Because 
MedLN are not visible in noninfected mice, we compared fre-
quencies of infection-induced IgM secretors with those found in 
nonstimulated peripheral LN (PLN). Infl  uenza IgM-secreting 
B-1 cells (eff  ector B-1 cells) accumulated in MedLN within 5 d 
of infection, which is comparable to the responses by B-2 cells 
(  Fig. 4 A  ).   Infl  uenza IgM-secreting B-1 cells were not found in 
PLN (unpublished data). BALB/c mice showed a similar accu-
mulation of infl  uenza IgM-secreting AFCs in MedLN although 
somewhat faster kinetics of the response (  Fig. 4 B  ). In the 
spleen, eff  ector B-1 cells were found to comparable frequencies 
before and after infection (  Fig. 4 C  ), which is consistent with 
the unchanged levels of B-1 cell  –  derived serum IgM (  Fig. 2 A  ). 
Interestingly, the frequencies of virus-specifi  c IgM AFCs were 
consistently reduced in the lung tissue of BALB/c mice and 
chimeras after infection (unpublished data), suggesting that the 
BAL IgM is not produced solely by cells residing in the lung. 
  To determine the phenotype of the B cell subset that 
generated the local IgM response to infl  uenza virus infection, 
we conducted IgM ELISPOT analysis on FACS-purifi  ed 
MedLN B cells from BALB/c mice, which were separated 
into four subsets according to expressions of surface IgM and 
    Figure 3.         IgM is a major virus-neutralizing activity in BLF of non-
infected and infected mice.   BLFs from noninfected and day-7 infected 
BALB/c mice (  n   = 12 per time point) were pooled and analyzed for HI 
activity before and after depletion of IgM by affi  nity chromatography. 
(A) ELISA analysis, performed for each sample in triplicate, confi  rmed the 
presence of virus IgM in the unfractionated BLF and then the complete 
removal of virus IgM by this procedure. Data shown are the mean   ±   SD 
relative concentrations (in units per milligram of total protein) of virus-
specifi  c IgM in BLF samples before (dark gray) and after (light gray) IgM 
depletion. (B) Shown are relative decreases (in percentage) in HI titers of 
BLF after removal of IgM (light gray) compared with the complete BLF 
samples before IgM was removed (dark gray). *, HI activity of total BLF 
from noninfected mice was not titrated out fully. Relative decrease of HI 
titer after IgM depletion was at least 75%. Results are from one represen-
tative sample of triplicates in all assays. (C) Mean   ±   SD relative units of 
infl  uenza-binding total Ig (in units per milliliter of BLF), i.e., virus IgM, IgG, 
and IgA, were determined in triplicate BLF samples before and after IgM 
depletion (dark gray and light gray, respectively) by ELISA.     JEM VOL. 205, December 22, 2008 
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levels on MedLN B-1 cells (  Fig. 4 C  ) despite their ability to 
secrete IgM (  Fig. 4  ). Together, these results demonstrate that 
IgM  hi   IgD  lo   CD19  +   CD24  interm   CD38  hi   CD43  +   CD138        and 
CD5  +   or CD5        B-1 cells actively participate in the local im-
mune response to infl  uenza virus infection by accumulating 
in the draining LN at the site of infection, but not in infected 
tissues, and by diff   erentiating to IgM  +   antibody-secreting 
cells that lack signs of terminal diff  erentiation. 
  Local B-1 cell responses lack signs of antigen-
specifi  c activation 
  Respiratory tract B-1 cell responses were measurable by day 5 
of infection and peaked around day 7 (  Fig. 4 A  ). B-1 cells were 
not found among the CD24  hi  CD38  lo   (  28, 31  ) germinal center 
  FACS analysis of MedLN from day-7 infected mice with 
allotypes-specifi  c anti-IgMa and -IgDa revealed the presence 
of B-1 cells (    1% of CD19  +   cells), which expressed surface 
Ig at levels comparable to that of peritoneal cavity B-1 cells 
(  Fig. 5 A  ).   Frequencies of B-1 cells were also determined in 
spleen and PLN (  Fig. 5 B  ). Consistent with the ELISPOT 
data (  Fig. 4  ), increased frequencies of B-1 cells after infl  uenza 
infection were seen only in MedLN but not PLN or spleen 
(  Fig. 5 B  ). Donor-derived B-1 (IgMa  +   IgDa  +  ) cells were 
larger in size and expressed higher levels of CD19 than host-
derived B-2 cells. In addition, they expressed CD43 consis-
tent with the known phenotype of B-1 cells (  Fig. 5 C  ) (  28, 
29  ). Consistent with studies by others (  30  ), CD138, a marker 
of diff  erentiated plasma cells, was not expressed to signifi  cant 
    Figure 4.         Infection-induced accumulation of IgM-secreting B-1 cells in local LN.   (A) Shown are the mean frequencies   ±   SD of virus-specifi  c IgM-
secreting B-1 (Igh-a) and B-2 (Igh-b) cells in MedLN after infection of Ig allotype chimeras with A/Mem/71 (  n   = 3 and 4, respectively, per time point). Re-
sults are from two independent ELISPOT analyses conducted on days 5 and 7 (experiment (Expt.) 1, left) and 7 and 10 (experiment 2, right), after infection. 
Results represent one of two sets of experiments done that yielded comparable results. (B) Virus-specifi  c IgM-secreting B cells were enumerated in the 
MedLN of BALB/c mice (  n   = 4 per time point) for comparison. Shown are the mean frequencies   ±   SD of virus-specifi  c IgM-secreting cells. n.d., not detect-
able by eye. (C) Frequencies of infl  uenza virus  –  specifi  c IgM-secreting B-1 cells in the spleens of individual chimeras assessed by ELISPOT at the indicated 
times after infection. Data are from one of two independent experiments that yielded similar results. Bars show the means. (D) Shown is a 5% contour 
plot (left) of CD19  +   B cells from MedLN of day-7 infected BALB/c mice after exclusion of dead cells and T cells (CD4 and 8). Cells were sorted as indicated 
into four populations based on IgM and CD43 expression. Total and virus-specifi  c IgM-secreting B cells were enumerated for each subset by ELISPOT.     3058 LOCAL B-1A CELL RESPONSES DURING INFLUENZA INFECTION   | Choi and Baumgarth 
expansion of these cells, we studied the rate of BrdU incorpo-
ration within the individual B cell subsets of MedLN from 7-d 
infected mice. The mice received BrdU via injection and 
drinking water for 24 h before tissue harvest. Frequencies of 
BrdU  +   cells within each B cell compartment were compared 
with those in PLN of sham-infected controls (  Fig. 6 C  ). Data 
are expressed as fold diff  erences in BrdU incorporation be-
tween LN B cell subsets in infected and sham-infected mice. 
The data revealed the strong infection-induced proliferation 
among conventional B cell subsets in MedLN, particularly the 
IgM        CD43  hi   plasmablasts (  Fig. 6 C  ). In striking contrast, there 
was a complete lack of infl  uenza infection  –  induced increases in 
B-1 (IgM  hi  IgD  lo  CD19  hi  CD43  +  ) cell proliferation in MedLN, 
implying that these cells do not undergo signifi  cant antigen-
driven expansion at the site. All splenic B cell subsets from the 
same mice lacked signs of proliferation beyond those found in 
sham-infected controls (  Fig. 6 C  ), underscoring the tissue-
specifi  c nature of the humoral response at this time point. 
Consistent with a lack of local expansion, B-1 cells in MedLN 
and in the (nonresponding) spleen had similar forward scatter/
side scatter profi  les, further suggesting that MedLN B-1 cells 
did not undergo blast transformation (  Fig. 6 D  ). 
  Importantly, the majority of B-1 cells (  >  70%) in the 
MedLN expressed the BCR-signaling inhibitor CD5 and thus 
were B-1a cells (  Fig. 6 D  ). Together, these results show that 
the highly localized B-1 cell response to infl  uenza virus infec-
tion is facilitated by the increased accumulation, not expan-
sion, of B-1a cells in the regional LN at the site of infection. 
  B-1a cells actively participate in the local immune response 
to infl  uenza virus infection 
  Our fi  ndings of an active response by B-1a cells are in appar-
ent contrast to recent studies that suggested a mainly passive 
role for B-1a cells as steady-state natural antibody producers 
during systemic bacterial infections (  17  ). To compare the 
ability of B-1a and B-1b cells to respond to infl  uenza virus 
infection, we generated irradiation Ig allotype chimeras with 
either FACS-purifi  ed peritoneal cavity B-1a or B-1b cells, or 
total PerC as controls (  Fig. 7 A  ).   Successful reconstitution of 
the animals was confi  rmed by serum ELISA. Overall serum 
IgM levels in these reconstituted animals were lower than in 
neonatal antibody-treated chimeras or normal mice (unpub-
lished data); however, this is likely because of the relative 
smaller number of transferred B-1 cells. 
  The small frequency of B-1a and B-1b cells that was co-
transferred with the purifi  ed B-1 cell subset of interest seemed 
to have homeostatically expanded during the 6-wk reconsti-
tution phase (compare purities of the input cells [  Fig. 7 A  ] 
with the peritoneal cavity B-1 cell subset frequencies for each 
group [  Fig. 7 B  , top left]). Nonetheless, a relative enrichment 
of the transferred FACS-purifi  ed B-1 subset remained in the 
recipient mice compared with mice receiving total washouts 
(  Fig. 7 B  , PerC). Analysis on day 7 after infection with infl  u-
enza showed that mice that received purifi   ed B-1a cells 
showed similar overall frequencies of B-1a and B-1b cells in 
all of the studied tissues compared with those that received 
(GC) B cells that develop and expand in the MedLN around 
day 6/7 after infection (  Fig. 6 A  ).   More than 20% of GC B cells 
expressed host-derived IgMb. The others were surface IgM and 
IgD negative (unpublished data) and, thus, we would have ex-
pected to identify IgMa  +   GC B cells had they been induced. 
  To determine whether there was evidence for extrafollicu-
lar clonal expansion of virus-specifi  c IgM-secreting eff  ector 
B-1 cells in MedLN, i.e., whether the B-1 cell response 
showed signs of antigen specifi  city, we compared the frequen-
cies of virus-specifi  c eff  ector B-1 cells over total IgM-secreting 
B-1 cells at days 7 and 10 of infection. On both days studied, 
the virus-specifi  c eff  ector B-1 cells made     10% of the total B-1 
cells that accumulated in the MedLN after infection (  Fig. 6 B  ). 
Thus, we found no evidence for a preferential expansion of 
virus-specifi  c B-1 cells in MedLN. Similar frequencies of virus 
IgM  –  secreting B-1 cells were also observed in the spleen of 
mice before and after infection, further suggesting that the in-
fection does not cause an expansion of virus-binding B-1 cells 
and that any increased secretion of B-1 cell  –  derived IgM was 
the consequence of infection-induced immune signals rather 
than a response to a particular viral antigen. 
  To determine whether the observed increases in MedLN 
B-1 cells after infection were caused by recruitment or clonal 
    Figure 5.         Characterization of B-1 cells in MedLN after infl  uenza 
virus infection.   (A) Shown is a 5% contour plot with outliers (left) of live 
CD19  +   B cells from day-7 infl  uenza-infected Ig allotype chimeras after 
exclusion of dead cells, T cells (CD3, 4, and 8), macrophages (F4/80), NK 
cells (DX-5), and granulocytes (GR-1). B-1 cells in MedLN were identifi  ed 
by their expressions of IgMa and IgDa. Overlay dot plot (right) of MedLN 
B-1 cells (blue dots) with similarly gated CD19  +   B cells from the perito-
neal cavity (PerC, red dots) showed their similar phenotype. (B) Shown are 
the mean frequencies   ±   SD of IgMa  +   IgDa +   B-1 cells in spleen (SPL), 
MedLN, and PLN of chimeras on days 0 and 7 after infection. n.d., not 
detectable by eye. (C) Shown are histogram overlay diagrams for forward 
side scatter (FSC) and indicated cell surface markers on IgMa  + IgDa +   B-1 
cells (red lines) and IgMa      IgDa       host B-2 cells (blue lines) with negative 
control staining (gray-fi  lled histogram), gated as outlined for A. Results 
shown are representative of two experiments that yielded similar results.     JEM VOL. 205, December 22, 2008 
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activation of B-1a cells after infl  uenza virus infection and 
their local accumulation and diff  erentiation to IgM-secreting 
cells in the regional LN draining the site of infection. 
    DISCUSSION   
  We previously showed that B-1 and B-2 cell  –  derived IgM 
are nonredundant components of the protective response to 
acute infl  uenza virus infection (  26  ). B-1 cell  –  derived immu-
nity appeared to be provided via secretion of steady-state lev-
els of natural serum IgM levels that were unaff  ected  by 
infl  uenza virus infection. Extending our initial fi  ndings, we 
now provide evidence for an additional active role of B-1 
cells, namely as providers of enhanced local (but not systemic) 
IgM at the site of infection. Importantly, we show that B-1a 
cells are the main B-1 cell subset contributing to the response, 
despite their expression of the BCR inhibitor CD5. This co-
nundrum is explained by our fi  ndings that B-1a cell responses 
are tissue restricted and not driven by antigen-specifi  c clonal 
expansion. Instead, they appear to be regulated by infection-
induced local infl  ammatory signals that cause B-1a cell accu-
mulation and, potentially, B-1a cell diff  erentiation. Thus, our 
data show that B-1a cells, which undergo apoptosis rather 
than activation after BCR cross-linking (  13  ), can nonetheless 
actively contribute to immune defenses against pathogens. 
total PerC. This included the respiratory tract draining 
MedLN, in which     80% of the B-1 cells were B-1a. In con-
trast, mice that received purifi  ed B-1b had increased frequen-
cies of B-1b over B-1a cells in PerC, PLN, and spleen. In the 
MedLN, however, these mice had more B-1a than B-1b 
cells. Thus, in all mice, independent of the type of B-1 cells 
they received, B-1 cells that accumulated in the MedLN 
were mostly of the B-1a subset (  Fig. 7 B  ). Even in B-1b re-
cipients, in which     25% of the B-1 cells in the PerC were B-1a, 
    65% of the B-1 cells in MedLN were B-1a cells. Moreover, 
although total B-1 cell numbers in MedLN were overall sim-
ilar in recipients of total PerC and B-1a cells (4,723   ±   1,512 
and 3,623  ±   1,469;  n   = 4), B-1 cell recovery from the MedLN 
of B-1b recipients was     20-fold lower (262   ±   80;   n   = 4), 
thus showing little recruitment of B-1 cells to the side of 
infection in mice that lack B-1a cells. 
  IgM-secreting B-1 (Igh-a) cells were found in each group 
of recipients (  Fig. 7 C  ). B-1b cell recipients had the smallest 
number of IgM-secreting B-1 cells. This further demonstrates 
that B-1a cells not only accumulate in the MedLN but also 
contribute the majority of the locally secreted IgM. Consis-
tent with studies in neonatal chimeras (  Fig. 6  ), roughly 5  –
  10% of these IgM-secreting cells were infl  uenza-binding IgM 
(  Fig. 7 C  ). Collectively, these results demonstrate the rapid 
    Figure 6.         Local B-1 cell response to infl  uenza virus is not antigen driven  . Groups of Ig allotype chimeras (  n   = 2 or 3 per time point) were infected 
with infl  uenza A/Mem/71. (A, left) A 5% contour plot of live CD19  +   B cells in MedLN from day-7 infected mice after exclusion of dead cells (propidium 
iodide  +  ) and/or antibodies against markers for T cells (CD3, 4, and 8), macrophages (F4/80), NK cells (DX-5), and granulocytes (GR-1). GC and non-GC B 
cells were identifi  ed based on their expression of CD24 and CD38. (A, right) The presence of IgMa  + IgDa +   B-1 cells is revealed only in the non-GC fraction. 
(B) Shown are mean frequencies   ±   SD of total and virus-specifi  c IgM-secreting B-1 (Igh-a) cells in MedLN at the indicated days after infl  uenza infection. 
Results are representative of two fl  ow cytometry experiments and four ELISPOT analyses. Statistical signifi  cance was assessed by a two-tailed Student  ’  s 
  t   test (*, P   <   0.05). (C) Two groups of BALB/c mice (  n   = 4 per group) were either infected with infl  uenza A/Mem/71 or sham infected for 7 d. BrdU was given 
24 h before analysis. Shown are fold differences in frequencies of BrdU  +   cells for each indicated B cell subset between infl  uenza infected and sham-in-
fected mice. B cells were identifi  ed as total B (CD19  +  ), naive B (IgM  lo IgD hi CD43      ), plasma (IgM      CD43 hi  ), and B-1 (IgM  hi gD lo CD19 hi CD43 +  ) cells in MedLN 
and spleens. Error bars show SD. (D) Shown are overlay histograms for forward side scatter (left) and expression of CD5 (right) on B-1 cells in MedLN 
(black line) compared with B-1 cells in spleen (dark gray  –  fi  lled histogram, left) and host B-2 cells (light gray  –  fi  lled histogram, right). Cells were gated as in 
  Fig. 5 A  . Results are from one of four experiments that yielded comparable results.     3060 LOCAL B-1A CELL RESPONSES DURING INFLUENZA INFECTION   | Choi and Baumgarth 
was partially dependent on the expression of TLR-4 (  32  ). 
Yang et al. (  23  ) also showed that B-1a cells migrate from the 
peritoneal cavity to the spleen after stimulation with LPS, where 
they proliferate and diff  erentiate into IgM-secreting plasma 
cells. Collectively, these data indicate that B-1 cells vigorously 
respond to innate, but not antigen-specifi  c, signals. 
  The lack of BCR-mediated activation is explained by the 
expression of CD5 on the majority of B-1 cells. CD5 func-
tions as negative regulator of TCR-mediated activation signals 
(  33  ), and studies in CD5      /      mice indicate a similar function 
on B-1a cells (  13  ). Induction of CD5 expression on B-1a cells 
might follow their positive selection on self-antigens (  10  ) at a 
particular stage during their development. Up-regulation of 
CD5 on B cells is also a hallmark of anergic B-2 cells (  34  ). 
Similar to anergic B-2 cells, CD5 expression on B-1a cells 
  Recent eff  orts by us and others have focused on elucidat-
ing the extent of B-1 cell responses to various pathogens in 
vivo (  15  –  17, 23, 26, 32  ). These studies were precipitated by a 
large number of earlier studies, which clearly showed that B-1 
cell responses diff  er in many ways from responses by conven-
tional (B-2) cells. Importantly, although B-2 cells are activated 
to proliferate, migrate, and diff  erentiate to antibody-secreting 
cells after BCR engagement, B-1 cells do not. Instead, they 
proliferate vigorously to mitogenic signals such as LPS and re-
spond to PMA in the absence of additional stimulation via cal-
cium ionophores (  13, 14  ). In addition, B-1 cell migration 
appears to be regulated, at least in part, by an innate immune 
signal provided via Toll-like receptors. In response to i.p. in-
jection of bacteria or bacterial components such as lipid A and 
peptidoglycan, B-1 cell migration from the peritoneal cavity 
    Figure 7.         B-1a cells are the major contributors of the IgM responses in regional LN after infl  uenza virus infection  . PerC cells from 24 BALB/c 
mice (Igh-a) were pooled and sorted into B-1a and B-1b by FACS. Total PerC and sorted B-1 cell subsets were transferred together with C.B.-17 BM cells 
into whole body  –  irradiated donor C.B.-17 (Igh-b) mice. (A) Shown are 5% contour plots with outliers of PerC cells before (top) and after (bottom) FACS 
purifi  cation into CD5  +   (B-1a) and CD5        (B-1b)  CD11b +   CD19 +   CD23       live PerC B-1 cells (not depicted). (B) Shown are results from the FACS analysis of 
indicated tissues from individual recipient chimeric mice after full reconstitution and infection with infl  uenza virus for 7 d. Contour plots are from one 
representative example of each group of mice (  n   = 4). Scatter plot indicates the relative frequencies of CD5  +   (B-1a;  fi  lled symbols) and CD5        (B-1b;  open 
symbols) cells among CD19  hi CD43 + IgMa +   cells in PerC (top left), MedLN (top right), PLN (bottom left), and spleen (bottom right) of recipient mice that had 
received either total PerC, B-1a, or B-1b cells. Each symbol represents the data from an individual animal and the bar indicates mean of the group. 
(C) Shown are the mean frequencies   ±   SD of total and virus-specifi  c IgM-secreting B-1 cells (Igh-a) in MedLN as assessed by ELISPOT with pooled samples 
from three to four mice per group and analyzed in triplicate.     JEM VOL. 205, December 22, 2008 
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that facilitate local B-1 cell activation will be important as a 
means to exploit the broadly reactive immunity provided by 
these cells. 
  An active participation of CD5  +   B-1a cells during infl  u-
enza infection is in apparent contrast to recent fi  ndings by 
others, which showed that only CD5        B-1b cells actively re-
sponded to systemic infection with   B. hermsii  , whereas B-1a 
cells provided steady-state levels of natural antibacterial IgM 
(  15, 16  ). Haas et al. (  17  ) also demonstrated distinct function-
alities of B-1a and B-1b cells in response to   S. pneumoniae   in-
fection. Using mice that lacked either B-1a or B-1b cells 
because of the lack of or overexpression of CD19, respec-
tively, they showed that only B-1b cells responded with 
PPS3-specifi  c antibody production after immunization with 
PPS-3 and heat-killed bacteria and they conferred immunity 
after infectious challenge. 
  From these studies a   “  division of labor  ”   between B-1a 
and B-1b cells was proposed, with B-1a cells providing pas-
sive protection via natural antibody production and B-1b 
cells responding actively to infection by providing antibodies 
and B cell memory (  19  ). However, although B-1a cells did 
not provide PPS-3  –  specifi  c responses (  17  ), they generated 
strong responses to the cell wall membrane-component phos-
phocholine after immunization or infection (  5, 6, 20  –  22  ). 
might function to inhibit their potential inappropriate activa-
tion in response to BCR ligation mediated by autoantigen. 
  Despite the inhibitory function of CD5,   >  70% of the B-1 
cells that accumulated in the regional LN in response to infl  u-
enza virus infection expressed CD5 (  Fig. 6  ), suggesting that 
most of the local B-1 cell responses were not driven by BCR-
mediated signals. Consistent with this, these locally accumu-
lating B-1 cells showed no signs of antigen-specifi  c expansion. 
Instead, the virus-specifi  c B-1 cells were recruited into the in-
fl  amed MedLN, but no other tissue, always in proportion to 
their relative frequencies in other tissues and at frequencies 
similar to those observed before infection (    10% of total 
IgM-secreting B-1 cells;   Fig. 6  ). Both virus-specifi  c and -
nonspecifi  c B-1 cells migrated and/or diff  erentiated into IgM-
secreting plasma cells in these infl  amed LN without any overt 
signs of proliferation, clonal expansion, or participation in GC 
responses (  Fig. 6  ). Whether clonal expansion of B-1 cells oc-
curred in tissues other than the MedLN cannot be formally 
excluded at this point. What argues against this is that there 
were no signs of increased B-1 cell numbers or B-1 cell  – 
derived IgM-secreting cells in spleen, pleural and peritoneal 
cavities, or lung (unpublished data). Indeed, frequencies of 
B-1 cells seem to diminish in many of these tissues (  Fig. 5   and 
not depicted), leading us to favor a model in which the re-
gional accumulation of B-1 cells is caused by a redistribution 
rather than an expansion of these cells after infection (  Fig. 8  ).   
  We previously demonstrated the importance of B-1 (and 
B-2) cell  –  derived IgM for survival from infl  uenza virus infec-
tion (  26  ) and showed the ability of natural B-1 cell  –  derived 
serum IgM to provide immune protection. More recently, 
Harada et al. (  35  ) also demonstrated the potency of unmutated 
IgM in AID      /      mice to provide immune protection from in-
fl  uenza virus infection. Our studies here provide further evi-
dence for the antiviral properties of natural IgM by showing 
their strong contribution to HI activity in the BLF (  Fig. 3  ). 
Whether IgM might also contribute to immune protection by 
mechanisms other than direct binding and neutralization or 
complement-mediated virus inhibition, as indicated by recent 
studies by Carroll et al. (  36  ), remains to be further evaluated. 
  If BCR-mediated activation does not drive B-1 cell re-
sponses to infl  uenza, what signals induce their responses? Al-
though it is only speculation at this point, given the strong 
evidence for innate signal-driven migration of B-1 cells (  23, 
32  ), we hypothesize that infection-induced proinfl  ammatory 
signals, such as IL-1, IL-6, or TNF-    , might play a role in the 
recruitment of B-1 cells to the site of infection. These cyto-
kines are induced locally as well as systemically after infection 
with infl  uenza virus (not depicted) (  37  ) and, thus, could in-
duce B-1 cells to leave their sites of residence in the body 
cavities, and also possibly the spleen, and to accumulate in 
draining infl  amed LN at the site of infection (  Fig. 4   and   Fig. 
5  ). There is clear evidence for the regulation of B cell re-
sponses by proinfl  ammatory cytokines. For example, IL-1 is 
required for local antiviral IgM responses to infl  uenza virus 
infection (  38  ), and IL-6 drives diff  erentiation of B cells to 
plasma cells upon viral infection (  39  ). Identifi  cation of signals 
    Figure 8.         Working model of B-1a activation during infl  uenza in-
fection.   After  infl  uenza virus infection, conventional (B-2) cell responses 
are characterized by infection-induced accumulation followed by vigorous 
antigen-specifi  c clonal expansion/proliferation and differentiation into 
mainly isotype-switched virus-specifi  c (black) antibody-secreting plasma-
blasts (CD19  lo IgM     IgD     CD43 hi CD138 +  ) in the regional LN at the site of 
infection. In contrast, B-1 cells (mostly B-1a) respond by similarly accumu-
lating locally in the draining LN but failing to expand in response to anti-
gen-specifi  c signals. Instead, local infl  ammatory signals might drive their 
differentiation into short-lived (CD5  + CD19 hi IgM + CD43 + CD138     )  IgM-se-
creting cells, thereby increasing local levels of poly-reactive virus-specifi  c 
(black) and virus-nonspecifi  c (gray) IgM at the site of infection. Without 
signifi  cant proliferation and/or antigen-specifi  c clonal expansion, the B-1a 
cell  –  derived IgM response is not likely dependent on AID expression.     3062 LOCAL B-1A CELL RESPONSES DURING INFLUENZA INFECTION   | Choi and Baumgarth 
  Mice.     6  –  12-wk-old female and male C.B-17 (Taconic) and BALB/c (The 
Jackson Laboratory) mice, as well as pregnant female C.B-17 mice, were pur-
chased and kept in microisolator cages under conventional housing conditions. 
Mice were used at 6  –  12 wk of age or used to generate chimeras according to 
protocols approved by the University of California, Davis Animal Use and 
Care Committee. Ig allotype chimeras were generated as previously described 
(  12, 44  ) to distinguish B-1 and B-2 cells and the IgM they secrete with help of 
allotype- and isotype-specifi  c mAb. In brief, newborn C.B-17 mice (Igh-b) 
received 0.1 mg of anti-IgMb (AF6-78.2.5) antibody i.p., purifi  ed by Hi-Trap 
Affi   nity Protein G Column (GE Healthcare) from serum-free tissue culture 
supernatants to deplete host (Igh-b) B cells. Antibody treatment was continued 
for 6 wk, giving biweekly injections of 0.2 mg for a total of 2 mg/mouse of 
anti-IgMb. 2 d after birth, mice also received 3  –  5   ×   10  6   PerC from 2-mo-old 
congenic BALB/c (Igh-a) mice as source for allotype disparate B-1 cells. Allo-
type chimeras were held for at least two additional months after cessation of 
antibody treatment before being used in experiments. 
  Irradiation Ig allotype chimeras were established by reconstituting lethally 
irradiated C.B-17 (Igh-b;   n   = 4/group) mice (650 rad of full body irradiation) 
with total PerC (2   ×   10  6   cells/mouse) or FACS-purifi  ed B-1a (2.2   ×   10  6   cells/
mouse) and B-1b cells (5.2   ×   10  5   cells/mouse) from BALB/c mice (Igh-a) to-
gether with 2   ×   10  6   BM cells from C.B-17 mice. We transferred the highest 
number of B-1b cells into each mouse that we could obtain from FACS purifi  ca-
tion of PerC pooled from 24 mice. B-1a cells were transferred at numbers that 
refl  ected their relative proportion in the PerC compared with B-1b cells (ratio 
of just over 4:1) as established by FACS. Irradiated Ig allotype chimeras were 
rested for 4  –  6 wk before the onset of experiments. Chimerism was confi  rmed 
by ELISA, which revealed the presence of total and virus IgM in the serum of 
noninfected reconstituted mice. The Animal Use and Care Committee of the 
University of California, Davis approved all procedures and experiments in-
volving mice. 
  BrdU incorporation.     For BrdU incorporation studies, groups of BALB/c 
mice (  n   = 4) either infected with A/Mem/71 or mock infected using PBS re-
ceived BrdU (1 mg/100   μ  l PBS) i.p. and additional BrdU ad libitum in the 
drinking water (1 mg/100 ml) on day 6 after infection. BrdU incorporation 
was analyzed 24 h later, i.e., on day 7 after infection. 
  ELISPOT.     To quantify total and virus-specifi  c B-1 and B-2 cell  –  derived IgM 
producers, 96-well plates (Multi-Screen HA Filtration; Millipore) were coated 
with 5   μ  g/ml of anti-IgM (mAb 331, not allotype-specifi  c) or 1,000 HAU/ml 
of purifi  ed A/Mem/71 as previously described (  43  ). After blocking with PBS 
with 4% BSA, serial dilutions of single cells from various tissues were incubated 
overnight in culture medium (RPMI 1640, 2 mM   l-  glutamine, 100   μ  g/ml of 
penicillin and streptomycin, 10% heat inactivated FCS, and 50   μ  M 2-ME) at 
37  °  C with 5% CO  2  . Binding was revealed with in house  –  generated biotinyl-
ated allotype-specifi  c anti-IgM (DS-1.1 for IgM  a   and AF6-78.2.5 for IgM  b  ) 
followed by SA-HRP (Vector Laboratories) and 3-amino-9-ethylcarbazole 
(Sigma-Aldrich). Spots were counted with the help of a stereomicroscope 
(Stemi 2000-C; Carl Zeiss, Inc.). Data are expressed as the number of total and 
virus-specifi  c IgM-secreting cells per input cells. 
  ELISA.     Total and virus-specifi   c serum IgM levels were determined by 
ELISA as described previously (  43  ). In brief, 5   μ  g/ml of anti-IgM (331) anti-
body and 1,000 HAU/ml of purifi  ed A/Mem/71 were coated onto 96-well 
plates (Maxisorb; Thermo Fisher Scientifi  c). After blocking nonspecifi  c pro-
tein binding, serially diluted serum was added to plates. Binding was revealed 
with biotinylated allotype-specifi  c anti-IgM antibodies as outlined under 
ELISPOT. Purifi  ed myeloma IgM from HPC-76 (IgM  a  ) and CBPC-112 
(IgM  b  ), respectively, served as standards. Arbitrary units of A/Mem/71-spe-
cifi  c IgM titers, defi  ned as U/ml, were determined by comparison to hyper-
immune sera from BALB/c (Igh-a) and C.B-17 (Igh-b) mice. Half-maximal 
binding of that serum at a predetermined dilution was set as 100 U. 
  BLF.     BLF was taken by instilling 1 ml of sterile-fi   ltered PBS through 
the trachea into the lung airways and aspirating it with help of a syringe. 
Collectively, our data and those of the   S. pneumoniae   model 
are not consistent with a mere passive role for B-1a cells. Instead, 
they indicate the need for strong (possibly innate) signals that in-
duce B-1a cell responses, possibly via pattern-recognition recep-
tor engagement of bacterial cell wall components in the case of 
  S. pneumoniae   and/or infl  ammatory-induced soluble stimuli 
such as cytokines, such as those induced in response to viral 
replication and virus-induced tissue destruction during infl  u-
enza virus infection. 
  Systemic B-1a responses are not apparent after infl  uenza 
virus infection (  Fig. 2   and   Fig. 4  ) (  2  ) but are readily detectable 
in response to   S. pneumoniae   infection (  21  ). This might be ex-
plained by the fact that   S. pneumoniae   induced a systemic infec-
tion in that study, whereas our studies with infl  uenza induced 
a local respiratory tract  –  restricted infection. The ability of B-1 
cells to respond in a localized tissue-restricted manner might 
have advantages for the host. B-1 cell  –  derived IgM is often 
poly-specifi  c and reactive to self-antigens, although it is usually 
nonpathogenic and of low affi   nity. However, when inappro-
priately activated, B-1 cells can contribute to the development 
of antibody-mediated pathology as shown with transgenic 
mice expressing BCR specifi  c to RBCs. B-1 cells developed 
normally in these mice and did not produce hemolytic ane-
mia-causing IgM until stimulated with LPS (  40  ). These data 
not only show that an innate signal alone is suffi   cient to cause 
B-1 cell activation and diff  erentiation, they also indicate that 
B-1 cell activation must be tightly controlled to prevent sys-
temic antibody-mediated autoimmunity. A sequestered local 
activation of B-1 cells in response to the vast majority of infec-
tions that we are exposed to at mucosal surfaces such as the re-
spiratory and the gastrointestinal tract reduce the risk of 
autoimmune induction, while at the same time providing a 
rapid response system to reduce pathogen expansion during 
early infection. Because of the poly-specifi  city of the response, 
local increased production of B-1 cell  –  derived IgM might also 
reduce the risk of secondary infections that are common after 
infl  uenza virus infection (  41  ). 
  In summary, based on the data provided in this study, we 
propose a working model of B cell regulation to infl  uenza (  Fig. 
8  ) in which mainly antigen-specifi  c signals drive clonal expan-
sion and diff  erentiation of B-2 cells, while at the same time in-
nate signals drive and target the movement and diff  erentiation 
of B-1a cells to the site of infection. Consequently,   “  useful  ”   
poly-specifi  c IgM responses are targeted to the site of infec-
tion, where they can confer immune protection against the 
primary infection as well as against potential superinfections by 
secondary infectious agents. 
  MATERIALS AND METHODS 
  Infl  uenza virus and intranasal infection.     Infl  uenza A/Mem/71, a reas-
sortant infl  uenza virus strain carrying the hemagglutinin of A/Memphis/1/71 
(H3) and the neuraminidase of A/Bellamy/42 (N1), was grown and harvested 
from the allantoic fl  uid of 10-d embryonated chicken eggs as previously de-
scribed (  42  ). Viral antigen was purifi  ed as previously described (  43  ). Mice were 
anesthetized with isofl  urane (MINRAD Inc.) and infected intranasally with a 
sublethal dose (12,000 PFU/mouse) of virus-containing allantoic fl  uid in 40   μ  l 
of sterile PBS. JEM VOL. 205, December 22, 2008 
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Cell-free supernatant was stored at     80  °  C until analyzed. Total protein levels 
in BLF were determined by Bradfort protein assay (Bio-Rad Laboratories). An-
tibody concentrations in BLF were normalized to total protein concentrations 
and expressed as IgM/protein (in micrograms/milligram) and virus-specifi  c 
IgM/protein (in units/milligram). 
  HI assay.     HI assay was performed with BLF from mice before and at 7 d af-
ter infection and before and after removal of IgM. IgM was removed from 
BLF by anti-IgM (mAb 331) column affi   nity chromatography with columns 
generated according to the manufacturer  ’  s instructions (AminoLink Cou-
pling Gel; Thermo Fisher Scientifi  c). Micro-HI assay was done as previously 
reported (  45  ). In brief, 25   μ  l of serially twofold-diluted BLF was incubated 
with 4 HAU A/Mem/71 in 25   μ  l using a 96-well plate and incubated at 
room temperature for 30 min. 25   μ  l of fresh chicken RBCs (Hemostat Labo-
ratories) at 1% (volume/volume) in PBS was added to each well and incu-
bated at room temperature for 1 h. Hemagglutination was determined by 
eye. HI titers were determined as the last reciprocal sample dilutions that 
fully inhibited infl  uenza virus hemagglutination. 
  Flow cytometry.     Single cell suspensions from PerC, spleen, PLN, and 
MedLN were stained exactly as outlined previously (  43  ) with the following 
antibody conjugates (in-house generated unless otherwise noted) at predeter-
mined optimal concentrations after Fc receptor block: CD3-Cy5-PE (145-
2C11), CD4-Cy5-PE (GK1.5; eBioscience); CD19-Cy5.5-allophycocyanin 
(6D5; Invitrogen); CD43-PE (S7), CD5-PE (53  –  7.8), and CD138-PE (BD); 
Streptavidin-QDot605A (Invitrogen); and CD8-Cy5-PE (53.6.7), F4/80-
Cy5-PE (F4/80), IgD-Cy7-PE (  11  –  26  ), and IgD  a  -Cy7-PE (AMS-9.1), IgM 
allophycocyanin (331), and IgM  b   allophycocyanin (AF6-68.2.5), IgM  a  -Biotin 
(DS-1.1), CD24-Cy5.5-PE (30F1.2), and CD38-FITC (clone 90). Propo-
dium iodide was added to stained cells at 1   μ  g/ml to discriminate dead cells. 
Intranuclear BrdU staining was identifi  ed as described previously (  46  ). 
  For FACS purifi  cation of B-1a and B-1b cells, cell populations were 
isolated from PerC of BALB/c (Igh-a) mice and stained as described previ-
ously (  43  ) with CD5-biotin (53  –  7.8), CD11b-Cy7-PE (Mac1), CD19-APC 
(ID3); CD23-FITC (B3B4; BD); and Streptavidin-QDot605A (Invitrogen). 
Data acquisition and sorting were done using a FACSAria (BD) equipped 
with lasers and optics for 13-color data acquisition (  46  ). Data analysis was 
done using FlowJo software (gift of A. Treestar, Tree Star Inc.). 
  Statistical analysis.     Statistical analysis was done using either the two-tailed 
Student  ’  s   t   test or the nonparametric one-way ANOVA test. Data were re-
garded as statistically signifi  cant at P   <   0.05. 
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